Literature DB >> 13811297

The schistosomicidal and toxic effects of some N-p-aminophenoxyalkylamides.

R F COLLINS, M DAVIS, N D EDGE, J HILL, H W READING, E R TURNBULL.   

Abstract

Several N-(omega-p-aminophenoxyalkyl)amides were active against Schistosoma mansoni in mice. One of the most effective, N-(5-p-aminophenoxypentyl)benzamide (M&B3002), acted more rapidly than lucanthone on adult worms but less rapidly than antimony potassium tartrate. It was inactive against immature worms. This compound and M&B2948A (N-(5-p-aminophenoxypentyl)phthalimide) were both active against S. mansoni in hamsters. In monkeys M&B2948A was inactive, whilst M&B3002 was not tested for therapeutic activity. Several of the compounds were examined for the production of visual impairment in cats. Although this property was not entirely absent, its incidence was very much lower in this amide series than among other omega-p-aminophenoxyalkyl derivatives not containing an amide group. M&B3002 and M&B2948A produced impairment of vision in only a small proportion of the large number of cats tested. The general toxicology of the two drugs was studied in several species, and also their absorption and excretion in mice and rats; this was to provide information for a clinical trial.

Entities:  

Keywords:  AMIDES/pharmacology; SCHISTOSOMA/pharmacology

Mesh:

Substances:

Year:  1959        PMID: 13811297      PMCID: PMC1481914          DOI: 10.1111/j.1476-5381.1959.tb00950.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN: 0366-0826


  11 in total

1.  The schistosomicidal activity of symmetrical diaminodiphenoxyalkanes.

Authors:  C G RAISON; O D STANDEN
Journal:  Br J Pharmacol Chemother       Date:  1955-06

2.  [The anti-bilharzial activity of N-(p-amsinophenoxy)-5-phthalimidopentane (RP 6171). Apropos of 43 cases of vesical bilharziasis caused by Schistoma haematobium].

Authors:  J SCHNEIDER; H SANSARRICQ
Journal:  Med Trop (Mars)       Date:  1959 Jul-Aug

3.  Experimental degeneration of the retina. IV. Dia-minodiphenoxyalkanes as inducing agents.

Authors:  A SORSBY; A NAKAJIMA
Journal:  Br J Ophthalmol       Date:  1958-09       Impact factor: 4.638

4.  Pharmacological effects of certain diaminodiphenoxy alkanes.

Authors:  N D EDGE; D F MASON; R WIEN
Journal:  Nature       Date:  1956-10-13       Impact factor: 49.962

5.  The progress of degenerative changes in schistosomes following the treatment of experimental infections with 1:7-bis (p-dimethylaminophenoxy) heptane.

Authors:  O D STANDEN
Journal:  Trans R Soc Trop Med Hyg       Date:  1955-09       Impact factor: 2.184

6.  The activity of p-aminophenoxyalkane derivatives against Schistosoma mansoni.

Authors:  A G CALDWELL; O D STANDEN
Journal:  Br J Pharmacol Chemother       Date:  1956-12

7.  Effect of respiratory inhibition on Schistosoma mansoni.

Authors:  E BUEDING; L PETERS; S KOLETSKY; D V MOORE
Journal:  Br J Pharmacol Chemother       Date:  1953-03

8.  A new coupling component and simplified method for the estimation of sulphanilamide drugs.

Authors:  F L Rose
Journal:  Biochem J       Date:  1944       Impact factor: 3.857

9.  The schistosomicidal and toxic effects on some alphaomega-di (p-aminophenoxy)alkanes and related monoamines.

Authors:  R F COLLINS; M DAVIS; N D EDGE; J HILL
Journal:  Br J Pharmacol Chemother       Date:  1958-09

10.  The toxicity of diaminodiphenoxyalkanes.

Authors:  L G GOODWIN; W H RICHARDS; V UDALL
Journal:  Br J Pharmacol Chemother       Date:  1957-12
View more
  2 in total

1.  Evaluation of the treatment of human Schistosoma mansoni infection by the quantitative oogram technique.

Authors:  J R Cançado; A S da Cunha; D E Carvalho DG; D G Carvalho; J N Cambraia
Journal:  Bull World Health Organ       Date:  1965       Impact factor: 9.408

2.  The antischistosomal and retinotoxic effects of some nuclear substituted aminophenoxyalkanes.

Authors:  R F Collins; V A Cox; M Davis; N D Edge; J Hill; K F Rivett; M A Rust
Journal:  Br J Pharmacol Chemother       Date:  1967-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.